Covid-19: Abu Dhabi authorizes Valneva’s vaccine for emergency use

PARIS (Agefi-Dow Jones)–The biotechnology company Valneva announced on Monday that the United Arab Emirates had granted authorization for the emergency use of its inactivated and adjuvanted vaccine against Covid-19, VLA2001.

“This follows the conditional marketing authorization in the UK granted last month by the British health agency, and the authorization for the emergency use of the vaccine granted by the agency Bahrain Health Authority in March 2022,” Valneva said in a statement.

-Dimitri Delmond, Agefi-Dow Jones; +33 (0)1 41 27 47 31; [email protected] ed: JXM

Agefi-Dow Jones The financial newswire

Dow Jones Newswires

May 16, 2022 01:22 ET (05:22 GMT)